University Hospital of Ghent
Welcome,         Profile    Billing    Logout  
 19 Trials 
23 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lambert, Jo
BeNeBio, NCT04340076: Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis

Active, not recruiting
4
244
Europe
Secukinumab, Cosentyx, Ixekizumab, Taltz, Brodalumab, Kyntheum, Guselkumab, Tremfya, Risankizumab, Skyrizi, Tildrakizumab, Ilumetri, Bimekizumab, Bimzelx
Radboud University Medical Center, ZonMw: The Netherlands Organisation for Health Research and Development, Belgium Health Care Knowledge Centre, University Hospital, Ghent
Psoriasis, Psoriasis Vulgaris
12/25
12/25
BIOLOPTIM-SEC, NCT04080661: Therapeutic Drug Monitoring of Secukinumab in Psoriasis Patients.

Completed
4
82
Europe
Venapuncture, Patient questionnaires
University Hospital, Ghent, KU Leuven, University Ghent
Psoriasis Vulgaris
12/23
12/23
BIOLOPTIM-GUS, NCT04080648: Therapeutic Drug Monitoring of Guselkumab in Psoriasis Patients

Completed
4
79
Europe
Venapuncture, Patient questionnaires
University Hospital, Ghent, KU Leuven, University Ghent
Psoriasis Vulgaris
12/23
12/23
BIOLOPTIM-RIS, NCT05685940: Therapeutic Drug Monitoring of Risankizumab in Psoriasis Patients

Recruiting
4
100
Europe
Venapuncture, Patient questionnaires
University Hospital, Ghent
Psoriasis Vulgaris
12/24
12/24
BIOLOPTIM-IXE, NCT04083612: Therapeutic Drug Monitoring of Ixekizumab in Psoriasis Patients

Completed
4
49
Europe
Venapuncture, Patient questionnaires
University Hospital, Ghent, KU Leuven, University Ghent
Psoriasis Vulgaris
12/23
12/23
BIOLOPTIM-TIL, NCT05683015: Therapeutic Drug Monitoring of Tildrakizumab in Psoriasis Patients

Recruiting
4
100
Europe
Venapuncture, Patient questionnaires
University Hospital, Ghent
Psoriasis Vulgaris
12/24
12/25
HELIOS, NCT06398106: Proactive TDM Versus Standard Use of Biologics in Psoriasis

Not yet recruiting
4
210
Europe
Proactive TDM-based dosing of secukinumab, Cosentyx, Proactive TDM-based dosing of ixekizumab, Taltz, Proactive TDM-based dosing of guselkumab, Tremfya
University Hospital, Ghent, Belgium Health Care Knowledge Centre
Psoriasis Vulgaris
03/28
03/28
BIOLOPTIM-BRO, NCT04080635: Therapeutic Drug Monitoring of Brodalumab in Psoriasis Patients

Recruiting
N/A
100
Europe
Venapuncture, Patient questionnaires
University Hospital, Ghent, KU Leuven, University Ghent
Psoriasis Vulgaris
12/24
12/24
IRIS, NCT05480917: Value Based Healthcare in Psoriasis

Recruiting
N/A
350
Europe
Patients receiving PsoPlus care
University Hospital, Ghent, Novartis, Janssen, LP, Vlerick Business School, Scientific Research Foundation-Flanders
Psoriasis
03/25
09/25
DWORZAK, Michael
I-CML-Ped, NCT01281735: International Chronic Myeloid Leukemia Pediatric Study

Recruiting
N/A
750
Europe, Japan, RoW
Poitiers University Hospital, CIC Inserm 1402, University of Milano Bicocca, University Medical Center Groningen, University of Liege, Imperial College London, University Hospital Dresden, International BFM Study Group
Chronic Myeloid Leukemia
12/28
12/28
DRESSE, Marie Françoise
FORUM, NCT01949129 / 2012-003032-22: Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

Recruiting
2/3
1800
Europe, Canada, RoW
VP16, Etoposide, TBI, Thiotepa, Thio, Treosulfan, Treo, Fludarabine, Flu, Busulfan, Bu, ATG Thymoglobulin, ATG Thymo, Cyclophosphamide, Cy, Grafalon, Anti-human T-lymphocyte immunoglobulin
St. Anna Kinderkrebsforschung, ALL SCTped Forum, European Society for Blood and Marrow Transplantation, ALL-BFM Study Group, Assistance Publique - Hôpitaux de Paris, Dutch Childhood Oncology Group, Swiss Pediatric Oncology Group, Australian & New Zealand Children's Haematology/Oncology Group
Acute Lymphoblastic Leukaemia
06/25
04/30
I-CML-Ped, NCT01281735: International Chronic Myeloid Leukemia Pediatric Study

Recruiting
N/A
750
Europe, Japan, RoW
Poitiers University Hospital, CIC Inserm 1402, University of Milano Bicocca, University Medical Center Groningen, University of Liege, Imperial College London, University Hospital Dresden, International BFM Study Group
Chronic Myeloid Leukemia
12/28
12/28
Moerloose, Barbara de
NOPHO-DBH, NCT01828489 / 2012-002934-35: Research Study for Treatment of Children and Adolescents With Acute Myeloid Leukaemia 0-18 Years

Recruiting
3
300
Europe, RoW
Randomisation course 1 mitoxantrone versus DaunoXome, Randomisation course 2 ADxE versus FLADx
Vastra Gotaland Region
Pediatric Acute Myeloblastic Leukemia
03/18
03/23
HEM-iSMART D, NCT05658640: HEM ISMART-D: Trametinib + Dexamethasone + Chemotherapy in Children with Relapsed or Refractory Hematological Malignancies

Recruiting
1/2
26
Europe, RoW
Trametinib, Dexamethasone, Cyclophosphamide, Cytarabine, Intrathecal chemotherapy
Princess Maxima Center for Pediatric Oncology, Innovative Therapies For Children with Cancer Consortium, IBFM, Fight Kids Cancer
Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Refractory
04/29
04/29
I-CML-Ped, NCT01281735: International Chronic Myeloid Leukemia Pediatric Study

Recruiting
N/A
750
Europe, Japan, RoW
Poitiers University Hospital, CIC Inserm 1402, University of Milano Bicocca, University Medical Center Groningen, University of Liege, Imperial College London, University Hospital Dresden, International BFM Study Group
Chronic Myeloid Leukemia
12/28
12/28
Bekaert, Marlies
SCRIPT-AML, NCT05477589: Studying Conditioning Regimen In Pediatric Transplantation - AML ,

Recruiting
3
170
Europe, RoW
busulfan, cyclophosphamide and melphalan, BuCyMel, BuCyMel, clofarabine, fludarabine and busulfan, CloFluBu, CloFluBu
Vastra Gotaland Region
Acute Myeloid Leukemia (AML) in Remission, Stem Cell Transplantation
12/29
12/31
I-CML-Ped, NCT01281735: International Chronic Myeloid Leukemia Pediatric Study

Recruiting
N/A
750
Europe, Japan, RoW
Poitiers University Hospital, CIC Inserm 1402, University of Milano Bicocca, University Medical Center Groningen, University of Liege, Imperial College London, University Hospital Dresden, International BFM Study Group
Chronic Myeloid Leukemia
12/28
12/28
FERSTER, Alina
FORUM, NCT01949129 / 2012-003032-22: Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

Recruiting
2/3
1800
Europe, Canada, RoW
VP16, Etoposide, TBI, Thiotepa, Thio, Treosulfan, Treo, Fludarabine, Flu, Busulfan, Bu, ATG Thymoglobulin, ATG Thymo, Cyclophosphamide, Cy, Grafalon, Anti-human T-lymphocyte immunoglobulin
St. Anna Kinderkrebsforschung, ALL SCTped Forum, European Society for Blood and Marrow Transplantation, ALL-BFM Study Group, Assistance Publique - Hôpitaux de Paris, Dutch Childhood Oncology Group, Swiss Pediatric Oncology Group, Australian & New Zealand Children's Haematology/Oncology Group
Acute Lymphoblastic Leukaemia
06/25
04/30
NCT03590171: International Study for Treatment of High Risk Childhood Relapsed ALL 2010

Recruiting
2
250
Europe, RoW
Bortezomib
Charite University, Berlin, Germany, Australian & New Zealand Children's Haematology/Oncology Group, St. Anna Kinderkrebsforschung, CCRI (co-sponsor, Austria), European Organisation for Research and Treatment of Cancer - EORTC, University Hospital Motol (Co-Sponsor Czech Republic), Copenhagen University Hospital, Rigshospitalet (co-sponsor, Denmark), Turku University Central Hospital (co-sponsor, Finland), Centre Hospitalier Universitaire de Nice, Our Lady's Chilrden's Hospital (Co-Sponsor Ireland), Tel Aviv Sourasky Medical Centre (Co-Sponsor Israel), Ospedale Pediatrico Bambino (co-sponsor, Italy), Prinses Máxima Centrum (Co-Sponsor Netherlands), Oslo University Hospital (co-sponsor, Norway), Medical University of Wroclaw (Co-Sponsor Poland), Instituto Português de Oncologia de Lisboa (co-sponsor, Portugal), Karolinska University Hospital Stockholm (co-sponsor, Sweden), Spanish Society of Pediatric Hematology and Oncology (SEHOP) (Co-Sponsor Spain), University Children's Hospital, Zurich, Central Manchester University Hospitals NHS Foundation Trust (co-sponsor, UK)
Acute Lymphoblastic Leukemia (ALL)
12/27
12/27
CHANCE, NCT02595255: AMH as a Predictor of Infertility Risk in Children With Cancer

Recruiting
N/A
275
Europe
No intervention
Erasme University Hospital, Queen Fabiola Children's University Hospital
Fertility Preservation, Lymphoma, Pediatrics Cancer, Gonadotropin-releasing Hormone Agonist
12/21
12/36
I-CML-Ped, NCT01281735: International Chronic Myeloid Leukemia Pediatric Study

Recruiting
N/A
750
Europe, Japan, RoW
Poitiers University Hospital, CIC Inserm 1402, University of Milano Bicocca, University Medical Center Groningen, University of Liege, Imperial College London, University Hospital Dresden, International BFM Study Group
Chronic Myeloid Leukemia
12/28
12/28
Hindryckx, Pieter
POELH-II, NCT05678218: Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma

Recruiting
N/A
200
Europe
Endoscopic Ultrasound registration
Erasmus Medical Center
Hilar Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma, Common Bile Duct Neoplasms, Cholangiocarcinoma, Adenocarcinoma
02/25
02/26
LABOR, NCT05640947: Endoscopic Ultrasound-guided Large Diameter Lumen-apposing Metal Stent Gastro-gastrostomy for Bypass Reversal in Patients With Roux-en-y Gastric Bypass

Recruiting
N/A
20
Europe
The Hot AXIOS™ Stent and Electrocautery-Enhanced Delivery System, LAMS
University Hospital, Ghent
Hypoglycemia, Gastric Outlet Obstruction, Steatohepatitis, Parenteral Support, Gastric Bypass
10/25
02/26

Download Options